Page last updated: 2024-08-24

terikalant and Ventricular Fibrillation

terikalant has been researched along with Ventricular Fibrillation in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Clerck, F; Lu, HR; Remeysen, P1
Curtis, MJ; Rees, SA2
Dorian, P; Mamalias, N; Newman, D; Qi, X; Varma, P1

Other Studies

4 other study(ies) available for terikalant and Ventricular Fibrillation

ArticleYear
Antifibrillary action of class I-IV antiarrhythmic agents in the model of ventricular fibrillation threshold of anesthetized guinea pigs.
    Journal of cardiovascular pharmacology, 1995, Volume: 26, Issue:1

    Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Atenolol; Benzopyrans; Chromans; Disease Models, Animal; Electric Stimulation; Electrocardiography; Encainide; Ethanolamines; Guinea Pigs; Heart; Heart Conduction System; Injections, Intravenous; Male; Metoprolol; Nebivolol; Phenethylamines; Piperidines; Sotalol; Sulfonamides; Ventricular Fibrillation; Verapamil

1995
Specific IK1 blockade: a new antiarrhythmic mechanism? Effect of RP58866 on ventricular arrhythmias in rat, rabbit, and primate.
    Circulation, 1993, Volume: 87, Issue:6

    Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Callithrix; Cardiac Pacing, Artificial; Chromans; Electrocardiography; Heart; Male; Myocardial Reperfusion Injury; Piperidines; Potassium Channels; Rabbits; Rats; Rats, Wistar; Tachycardia, Ventricular; Ventricular Fibrillation

1993
Further investigations into the mechanism of antifibrillatory action of the specific IK1 blocker, RP58866, assessed using the rat dual coronary perfusion model.
    Journal of molecular and cellular cardiology, 1995, Volume: 27, Issue:12

    Topics: Animals; Anti-Arrhythmia Agents; Chromans; Coronary Circulation; Male; Myocardial Ischemia; Perfusion; Piperidines; Potassium; Potassium Channels; Rats; Rats, Wistar; Ventricular Fibrillation

1995
Terikalant and barium decrease the area of vulnerability to ventricular fibrillation induction by T-wave shocks.
    Journal of cardiovascular pharmacology, 2002, Volume: 39, Issue:2

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Barium Compounds; Chlorides; Chromans; Dogs; Electric Countershock; Electrocardiography; Female; Infusions, Intravenous; Male; Piperidines; Ventricular Fibrillation; Ventricular Function

2002